Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2022.07.29.501978

Linguistic speech processing decreases with advancing age

Gillis, M.·Kries, J.·Vandermosten, M.·Francart, T.
View original source ↗Export metadata ↓

Abstract

BackgroundOlder adults process speech differently, but it is not yet clear how aging affects different levels of processing natural, continuous speech, both in terms of bottom-up acoustic analysis and top-down generation of linguistic-based predictions. We studied natural speech processing across the adult lifespan via electroencephalography (EEG) measurements of neural tracking. GoalsOur goals are to analyze the unique contribution of linguistic speech processing across the adult lifespan using natural speech, while controlling for the influence of acoustic processing. In particular, we focus on changes in spatial and temporal activation patterns in response to natural speech across the lifespan. Methods52 normal-hearing adults between 17 and 82 years of age listened to a naturally spoken story while the EEG signal was recorded. We investigated the effect of age on acoustic and linguistic processing of speech. Because age correlated with hearing capacity and measures of cognition, we investigated whether the observed age effect is mediated by these factors. Furthermore, we investigated whether there is an effect of age on hemisphere lateralization and on spatiotemporal patterns of the neural responses. ResultsOur EEG results showed that linguistic speech processing declines with advancing age. More-over, as age increased, the neural response latency to certain aspects of linguistic speech processing increased. Also acoustic neural tracking (NT) decreased with increasing age but in contrast to linguistic processing, older subjects showed shorter latencies for early acoustic responses to speech. No evidence was found for hemispheric lateralization in neither younger nor older adults during linguistic speech processing. Most of the observed aging effects on acoustic and linguistic processing were not explained by age-related decline in hearing capacity or cognition. However, our results suggest that the effect of decreasing linguistic neural tracking with advancing age at word-level is likely more due to an age-related decline in cognition than a robust effect of age. ConclusionSpatial and temporal characteristics of the neural responses to continuous speech change across the adult lifespan for both acoustic and linguistic speech processing. These changes may be traces of structural and/or functional change that occurs with advancing age. HighlightsO_LIWith increasing age, linguistic neural tracking of continuous speech decreases. C_LIO_LIWith increasing age, the processing speed of linguistic aspects of speech slows down. C_LIO_LIAging-related changes in word-level linguistic processing are affected by cognition. C_LIO_LIWith advancing age, tracking of speech acoustics decreases in the right hemisphere. C_LIO_LIOlder adults displayed earlier neural responses to speech acoustics. C_LI

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gillis, M., Kries, J., Vandermosten, M., Francart, T.. 2022-07-29. Linguistic speech processing decreases with advancing age. https://doi.org/10.1101/2022.07.29.501978

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗